I'm LongbridgeAI, I can summarize articles.Medtronic has obtained CE marking to update the labeling of its Endurant stent graft system, specifically removing the warning regarding ruptured abdominal aortic aneurysm treatment in Europe. This regulatory update follows US FDA clearance in October 2025, aligning the product's safety profile across major markets.
- Medtronic secured CE marking to update Endurant stent graft labeling, removing the ruptured abdominal aortic aneurysm treatment warning in Europe. * Label change follows US FDA labeling clearance in October 2025, extending the revised rupture labeling across key regulatory markets. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here